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Pharmacokinetics (PK) of drugs such as
gentamicin and theophylline is altered in
humans with spinal cord (SC) injury (Segal,
1985). These observations led us to suspect that
the PK of cyclosporine-A (CsA) might be al-
tered in experimental SC injury. Our goal was to
establish the best immunosuppressive strategy
with CsA for our rat model of traumatic SC
injury, in order to control the autoimmune
response seen after trauma and to control the
immune response to tissue grafts in transplanted
SC-lesioned rats. We determined the PK of CsA,
administered in a single dose of 10 mg/kg b.w., in
three groups of 10 rats each, as follows: Group
A: acutely SC-lesioned rats. Five rats were given
the drug orally and five received the drug
intraperitoneally one day after injury. Group B:
chronically SC-lesioned rats. Five rats were
given CsA orally and five received the drug
intraperitoneally 7-9 weeks after injury. Group
C: sham-lesioned rats. Five rats were given CsA
orally and five received the drug
intraperitoneally one day after laminectomy.
Blood samples were collected from the tail of
each anesthetized rat before and 2, 4, 6, 12 and
24 hours after drug administration. The serum
levels of CsA were determined by RIA, and the
PK parameters assessed were: maximum serum
concentration (Cmx), time to reach maximum
serum concentration (tmax) and area under the
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concentration-time curve (AUC). The results
showed that CsA bioavailability was altered in
acutely SC-lesioned rats. After oral administra-
tion, the bioavailability of CsA was statistically
significantly reduced; serum levels were barely
detectable after 12 hours. After intraperitoneal
administration this group of lesioned rats
showed an increase in CsA bioavailability com-
pared with the sham-lesioned and the chroni-
cally SC-lesioned rats.
Altered bioavailability after oral administra-
tion of CsA could be attributed to the delayed
gastric emptying secondary to spinal cord injury
resulting in a deficient absorption of CsA in the
upper small intestine. The altered bioavailability
after intraperitoneal administration may be at-
tributed to SC injury disturbances, such as vessel
dilatation by dominant parasympathetic action,
resulting in an increased drug absorption. On
the other hand chronically SC-lesioned rats
showed a CsA bioavailability profile similar to
that observed in sham-lesioned animals, after
both oral and intraperitoneal administration; the
differences in the CsA bioavailability were not
statistically significant. This may indicate that the
recovery in the gastrointestinal and vessel motor
functions tends towards normality in chronically
SC-lesioned rats.
Finally, sham-lesioned rats showed similar
bioavailability profiles to those of healthy rats, as
reported by other authors (Wassef et al., 1985).
The differences observed in CsA bioavail-
ability in SC-lesioned rats must be taken into
consideration in order to establish an adequate
immunosuppressive strategy.